Navigation Links
Omthera Pharmaceuticals, Inc. Announces Initiation of the ECLIPSE Trial: Epanova Compared to Lovaza In a Pharmacokinetic Single-dose Evaluation
Date:11/8/2010

BEDMINSTER, N.J., Nov. 8, 2010 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced the initiation of a randomized, open-label, four-way cross-over pharmacokinetics study to evaluate the bioavailability of Epanova™, Omthera's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega-3.  Epanova is an Omega-3 fatty acid compound containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The primary objective of the four-week study, called ECLIPSE (Epanova Compared to Lovaza In a Pharmacokinetic Single-dose Evaluation), is to compare the bioavailability of EPA from Epanova and Lovaza in either a low or high fat diet setting.  

The study will include 50 subjects.  In the four cross-over periods, all subjects will be given a single 4-gram dose of either Epanova or Lovaza with low and high fat meals.  Data is expected from this study in the first quarter of 2011.

"Several studies have compared the absorption of Omega-3 fatty acids in the ethyl ester and free fatty acid forms and found that the free fatty acid form has up to four times greater bioavailability. Given that Epanova is a free fatty acid form of EPA and DHA, whereas Lovaza is an ethyl ester EPA and DHA product, Epanova may offer distinct advantages in the marketplace," said Dr. Michael Davidson, Chief Medical Officer of Omthera Pharmaceuticals.  "Further, free fatty acid Omega-3s are well absorbed when given with a low fat meal and may therefore have clinical relevance in patients with hypertriglyceridemia who should be maintained on a low fat diet."

About Epanova™Epanova is a patent protected, novel, ultra-pure mixture of the free fatty acid forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).  Omthera has deve
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
2. Biostar Pharmaceuticals, Inc. Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500
3. OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering
4. OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
5. OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering
6. Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against the Company And Certain of Its Subsidiaries
7. OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
8. NanoSmart™ Pharmaceuticals, Inc. Receives Patent Allowance for Tumor Targeting Platform Technology
9. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010
10. Biostar Pharmaceuticals, Inc. Appoints New Chief Financial Officer
11. Melissa Kemp, Ph.D., Wins the Council for Systems Biology in Boston (CSB2) Award Sponsored by Merrimack Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Bellingham, WA (PRWEB) May 21, 2013 ... teacher trainings, and funds for lab equipment, 25 organizations ... relevance and importance of optics and photonics in daily ... Grants . , The organizations, located in 10 countries, ... grants to be awarded by SPIE, the international ...
(Date:5/21/2013)... 21, 2013 Alpha Source, Inc., ... will be exhibiting for the 13th consecutive year ... Instrumentation (AAMI) 2013 Conference and Expo. The conference ... and manufacture healthcare technologies. This year’s event will ... California. , The three-day event draws over ...
(Date:5/21/2013)... NJ (PRWEB) May 21, 2013 Savoury ... industry, has appointed Dale Braddy to Southeastern USA Sales ... bolster its sales muscle in the Southeast. ... food ingredient brokerage and supplier to food processors and ... 13 years in the food industry and has over ...
(Date:5/21/2013)... Austin, TX (PRWEB) May 21, 2013 ... and outdoor security solutions, today announced that Genzyme, a ... more units of Door Detective® CL for a multi-use ... already installed in four other Genzyme buildings, this latest ... had with the tailgate detection device improving ...
Breaking Biology Technology:Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3
... Monsanto Company (NYSE: MON ) announced today ... China, further demonstrating its commitment to forming technology collaborations ... Center in Zhongguancun, Beijing, will strengthen the company,s ties ... , The new research center is an extension ...
... ... a standard tool in the chemical and pharmaceutical industries for providing information ... development and scale-up of chemical processes. METTLER TOLEDO is offering a ... Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool ...
... Clarient, Inc. (Nasdaq: CLRT ), ... pathologists, oncologists and the pharmaceutical industry, today reported financial results ... 2009. Results included a 13 percent increase in net ... the third quarter of 2008. Third quarter net revenue ...
Cached Biology Technology:Monsanto Opens First Biotechnology Research Center in China 2Monsanto Opens First Biotechnology Research Center in China 3Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool 2Clarient Reports 2009 Third Quarter; Nine Month Results 2Clarient Reports 2009 Third Quarter; Nine Month Results 3Clarient Reports 2009 Third Quarter; Nine Month Results 4Clarient Reports 2009 Third Quarter; Nine Month Results 5Clarient Reports 2009 Third Quarter; Nine Month Results 6Clarient Reports 2009 Third Quarter; Nine Month Results 7Clarient Reports 2009 Third Quarter; Nine Month Results 8Clarient Reports 2009 Third Quarter; Nine Month Results 9Clarient Reports 2009 Third Quarter; Nine Month Results 10Clarient Reports 2009 Third Quarter; Nine Month Results 11
(Date:5/21/2013)... that the nation,s land and water resources could likely ... to 25 billion gallons of algae-based fuel a year ... needs. , The findings come from an in-depth look ... grow significant amounts of algae in large, specially built ... 7 issue of Environmental Science and Technology , ...
(Date:5/21/2013)... USC have found that a class of pharmaceuticals can ... , The drugs, known as "TSPO ligands," are currently ... at the effects of TSPO ligand in young adult ... in aged mice when pathology was quite severe," said ... of Gerontology. "TSPO ligand reduced measures of pathology and ...
(Date:5/21/2013)... COLUMBIA, Mo. Cancers of all types become most ... body. Once cancer has reached this stage, it becomes ... numerous tumors that can develop. Now, researchers at the ... radioactive nanoparticles that target lymphoma tumor cells wherever they ... professor of oncology in the MU College of Veterinary ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2
... NEW YORK (Dec. 15, 2008) Using stem cell ... Center have designed a new way to "grow" bone ... a physiological process involving the growth of new ... major roadblock in tissue regeneration. Previous approaches have included ...
... ecosystem smaller than a stick of gum that sheds new ... aquatic food chain. The work, reported in the January ... better predictions of marine microbes, global-scale influence on climate. ... marine microorganisms too small to be seen with the ...
... nervous system neurons may not look or act alike, but ... research from the University of North Carolina at Chapel Hill ... issue of Nature Cell Biology is the first ... the common goal of inhibiting the series of biochemical events ...
Cached Biology News:Columbia University scientist devises new way to more rapidly generate bone tissue 2Tiny MIT ecosystem may shed light on climate change 2Shared survival mechanism explains why 'good' nerve cells last and 'bad' cancer cells flourish 2
... The Ultra Silica Bead Kit has been designed for ... and solutions. Features Ultra fast ... Uniform silica beads are easy to resuspend ... Highly pure DNA (suitable for PCR) DNA ...
... Rapid, efficient extraction of DNA from agarose gels ... of DNA fragments of 150 bp to > 12,000 ... GelMelt solution to dissolve the gel slice, followed by ... a spin column format. After a wash step, the ...
BlotGel application pool -see Blotters (Semi-Dry) for more info...
Request Info...
Biology Products: